微型钛螺钉内固定加脱钙人牙基质材料促进陈旧性经舟月骨周围脱位的恢复疗效

目的:观察脱钙人牙基质材料与骨科植入物内固定治疗促进陈旧性经舟月骨周围脱位恢复的效果,并经远期随访。方法:选择1996-01/2005-10武汉市普爱医院8例陈旧性经舟月骨周围脱位病例,采用复位后微型钛螺钉内固定加脱钙人牙基质材料植入治疗。术后随访8周至3年。患者腕部功能采用Maya Modified Wrist Score法进行评估,优秀为91～100分;良好为80～90分;尚可为65～79分;差为<64分。结果:8例陈旧性经舟月骨周围脱位的舟骨骨折全部骨性愈合。优秀2例,良好3例,尚可2例,差1例。结论:微型钛螺钉内固定加脱钙人牙基质材料植骨操作简单,提高骨折愈合率,促进腕关节功能恢复,是促进陈旧性经舟月骨周围脱位恢复的一种有效方法。     

Percutaneous fluoroscopic removal of a knotted Swan–Ganz catheter in a patient with a persistent left‐sided superior vena cava

Knotting of intravascular catheters is an uncommon but a well‐recognized occurrence. The Swan–Ganz catheter (SGC) is the one that knots most commonly. A case of a knotted SGC is described in a patient with a persistent left‐sided superior vena cava, and we propose that the presence of a left‐sided superior vena cava is a risk factor for knot formation not previously reported. We review the published work on the risk factors for knot formation and on the techniques used to remove knotted SGC. We describe a technique using a gooseneck snare and Omni Flush catheter (Angiodynamics, Queensbury, NY, USA) to loosen and untie a knotted SGC.     

Strabismus in adults with uveal melanoma following episcleral plaque brachytherapy

PURPOSE: To ascertain the incidence of persistent strabismus in patients treated with plaque brachytherapy and its subsequent treatment. METHODS: A single center retrospective case note review of adult patients with persistent diplopia or strabismus following plaque brachytherapy for all types of intraocular tumors between 1996 and 2004. RESULTS: A total of 929 consecutive adults underwent plaque brachytherapy during the study period at a single center. Sixteen patients (1.7%) with treated uveal melanoma developed persistent diplopia or strabismus. In 11 patients (69%) the timing of onset was in the first year, in 2 (13%) in the second year, and one each (6% each) in years 5, 7, and 8. Two patients (13%) did not require any intervention. Fourteen patients (88%) required treatment: 7 (50%) were treated with prisms only, 3 (21%) underwent botulinum toxin (BTXA) injections, and 4 (29%) were treated with extraocular muscle surgery (3 required one operation and one required 2 procedures). CONCLUSIONS: The incidence of ocular motility disorders following plaque brachytherapy in our cohort was 1.7% over 8 years and we include this in the consent process for conservative treatment of intraocular tumors. Options for treatment for persistent diplopia or strabismus include prisms, botulinum toxin injection, or surgery.